China Research Development vs Selling General Administrative Analysis

603993 Stock

7.81 0.62 8.62%

China Molybdenum financial indicator trend analysis is way more than just evaluating China Molybdenum prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether China Molybdenum is a good investment. Please check the relationship between China Molybdenum Research Development and its Selling General Administrative accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Molybdenum Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Research Development vs Selling General Administrative

Research Development vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of China Molybdenum Research Development account and Selling General Administrative. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between China Molybdenum's Research Development and Selling General Administrative is 0.55. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of China Molybdenum Co, assuming nothing else is changed. The correlation between historical values of China Molybdenum's Research Development and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of China Molybdenum Co are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Research Development i.e., China Molybdenum's Research Development and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

0.55

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Research Development

Selling General Administrative

Most indicators from China Molybdenum's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into China Molybdenum current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Molybdenum Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 1 B. The current year's Tax Provision is expected to grow to about 5.6 B

	2022	2023	2024	2025 (projected)
Income Before Tax	9.8B	13.2B	15.2B	15.9B
Cost Of Revenue	156.9B	168.4B	193.7B	203.4B

Income Before Tax Cost Of Revenue

China Molybdenum fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total
Total Assets		0.96	0.96	0.98	0.97	0.95	0.84	0.94	0.99	-0.07	0.82	0.95	0.34	1.0	0.22	0.9	0.99	0.73	0.74	0.15	0.74	0.75	0.91	0.91	0.89	0.56
Other Current Liab	0.96		0.97	0.94	0.98	0.98	0.84	0.89	0.93	-0.3	0.86	0.98	0.34	0.97	0.02	0.78	0.94	0.55	0.83	0.18	0.83	0.72	0.95	0.92	0.92	0.68
Total Current Liabilities	0.96	0.97		0.92	0.93	0.93	0.9	0.85	0.94	-0.31	0.9	0.99	0.5	0.97	0.16	0.83	0.92	0.59	0.75	-0.01	0.77	0.79	0.97	0.93	0.97	0.56
Total Stockholder Equity	0.98	0.94	0.92		0.95	0.96	0.77	0.96	0.95	-0.02	0.82	0.92	0.25	0.96	0.12	0.89	0.96	0.67	0.82	0.22	0.73	0.68	0.88	0.89	0.85	0.57
Other Liab	0.97	0.98	0.93	0.95		0.97	0.84	0.94	0.95	-0.15	0.76	0.95	0.26	0.97	0.09	0.81	0.97	0.63	0.78	0.22	0.82	0.7	0.9	0.9	0.85	0.65
Retained Earnings	0.95	0.98	0.93	0.96	0.97		0.79	0.91	0.91	-0.24	0.85	0.95	0.2	0.94	-0.08	0.77	0.93	0.52	0.87	0.25	0.83	0.7	0.94	0.89	0.87	0.72
Accounts Payable	0.84	0.84	0.9	0.77	0.84	0.79		0.78	0.83	-0.28	0.7	0.88	0.63	0.87	0.32	0.76	0.81	0.54	0.61	-0.14	0.74	0.71	0.81	0.86	0.84	0.41
Cash	0.94	0.89	0.85	0.96	0.94	0.91	0.78		0.91	0.06	0.68	0.85	0.24	0.92	0.21	0.89	0.93	0.7	0.77	0.19	0.71	0.6	0.77	0.86	0.74	0.49
Other Assets	0.99	0.93	0.94	0.95	0.95	0.91	0.83	0.91		-0.02	0.77	0.92	0.38	0.99	0.32	0.91	0.99	0.78	0.65	0.13	0.69	0.78	0.87	0.89	0.87	0.5
Net Receivables	-0.07	-0.3	-0.31	-0.02	-0.15	-0.24	-0.28	0.06	-0.02		-0.39	-0.34	-0.34	-0.12	0.46	0.16	-0.01	0.41	-0.33	0.19	-0.45	-0.28	-0.41	-0.29	-0.41	-0.46
Short Term Investments	0.82	0.86	0.9	0.82	0.76	0.85	0.7	0.68	0.77	-0.39		0.9	0.36	0.82	-0.08	0.69	0.75	0.38	0.76	-0.03	0.67	0.68	0.95	0.8	0.94	0.56
Inventory	0.95	0.98	0.99	0.92	0.95	0.95	0.88	0.85	0.92	-0.34	0.9		0.44	0.96	0.06	0.77	0.92	0.53	0.82	0.09	0.82	0.76	0.97	0.94	0.97	0.63
Other Current Assets	0.34	0.34	0.5	0.25	0.26	0.2	0.63	0.24	0.38	-0.34	0.36	0.44		0.4	0.6	0.37	0.3	0.31	0.16	-0.49	0.25	0.44	0.36	0.49	0.55	-0.13
Total Liab	1.0	0.97	0.97	0.96	0.97	0.94	0.87	0.92	0.99	-0.12	0.82	0.96	0.4		0.24	0.89	0.99	0.72	0.72	0.1	0.75	0.76	0.92	0.92	0.91	0.55
Intangible Assets	0.22	0.02	0.16	0.12	0.09	-0.08	0.32	0.21	0.32	0.46	-0.08	0.06	0.6	0.24		0.46	0.25	0.67	-0.31	-0.38	-0.18	0.24	-0.06	0.16	0.11	-0.48
Common Stock	0.9	0.78	0.83	0.89	0.81	0.77	0.76	0.89	0.91	0.16	0.69	0.77	0.37	0.89	0.46		0.88	0.79	0.54	0.02	0.51	0.65	0.72	0.77	0.74	0.29
Property Plant Equipment	0.99	0.94	0.92	0.96	0.97	0.93	0.81	0.93	0.99	-0.01	0.75	0.92	0.3	0.99	0.25	0.88		0.77	0.68	0.23	0.72	0.74	0.86	0.88	0.84	0.56
Long Term Debt	0.73	0.55	0.59	0.67	0.63	0.52	0.54	0.7	0.78	0.41	0.38	0.53	0.31	0.72	0.67	0.79	0.77		0.21	0.11	0.4	0.6	0.44	0.65	0.49	0.22
Net Tangible Assets	0.74	0.83	0.75	0.82	0.78	0.87	0.61	0.77	0.65	-0.33	0.76	0.82	0.16	0.72	-0.31	0.54	0.68	0.21		0.27	0.77	0.47	0.79	0.78	0.74	0.64
Other Stockholder Equity	0.15	0.18	-0.01	0.22	0.22	0.25	-0.14	0.19	0.13	0.19	-0.03	0.09	-0.49	0.1	-0.38	0.02	0.23	0.11	0.27		0.24	-0.04	0.02	0.05	-0.04	0.47
Deferred Long Term Liab	0.74	0.83	0.77	0.73	0.82	0.83	0.74	0.71	0.69	-0.45	0.67	0.82	0.25	0.75	-0.18	0.51	0.72	0.4	0.77	0.24		0.7	0.79	0.89	0.74	0.88
Long Term Investments	0.75	0.72	0.79	0.68	0.7	0.7	0.71	0.6	0.78	-0.28	0.68	0.76	0.44	0.76	0.24	0.65	0.74	0.6	0.47	-0.04	0.7		0.76	0.78	0.8	0.56
Short Long Term Debt	0.91	0.95	0.97	0.88	0.9	0.94	0.81	0.77	0.87	-0.41	0.95	0.97	0.36	0.92	-0.06	0.72	0.86	0.44	0.79	0.02	0.79	0.76		0.88	0.97	0.65
Total Current Assets	0.91	0.92	0.93	0.89	0.9	0.89	0.86	0.86	0.89	-0.29	0.8	0.94	0.49	0.92	0.16	0.77	0.88	0.65	0.78	0.05	0.89	0.78	0.88		0.89	0.65
Short Term Debt	0.89	0.92	0.97	0.85	0.85	0.87	0.84	0.74	0.87	-0.41	0.94	0.97	0.55	0.91	0.11	0.74	0.84	0.49	0.74	-0.04	0.74	0.8	0.97	0.89		0.54
Non Current Assets Total	0.56	0.68	0.56	0.57	0.65	0.72	0.41	0.49	0.5	-0.46	0.56	0.63	-0.13	0.55	-0.48	0.29	0.56	0.22	0.64	0.47	0.88	0.56	0.65	0.65	0.54

Click cells to compare fundamentals

China Molybdenum Account Relationship Matchups

China Molybdenum fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	122.4B	137.4B	165.0B	173.0B	198.9B	208.9B
Other Current Liab	7.6B	11.6B	12.8B	18.1B	20.8B	21.8B
Total Current Liabilities	42.4B	50.7B	50.1B	49.0B	56.3B	59.1B
Total Stockholder Equity	38.9B	39.8B	51.7B	59.5B	68.5B	71.9B
Other Liab	10.9B	13.1B	23.2B	31.6B	36.3B	38.1B
Retained Earnings	10.8B	15.2B	19.7B	24.0B	27.6B	29.0B
Accounts Payable	1.5B	4.2B	4.0B	2.3B	2.7B	2.8B
Cash	16.9B	24.3B	32.6B	30.7B	35.3B	37.1B
Other Assets	8.9B	9.2B	9.8B	12.0B	13.8B	14.5B
Net Receivables	702.2M	745.9M	800.3M	1.1B	1.3B	2.1B
Short Term Investments	7.4B	7.1B	4.2B	8.3B	9.5B	10.0B
Inventory	21.2B	27.0B	32.3B	31.4B	36.1B	38.0B
Other Current Assets	8.8B	8.4B	10.3B	27.9M	32.0M	30.4M
Total Liab	75.1B	89.2B	103.0B	101.0B	116.2B	122.0B
Intangible Assets	21.5B	19.4B	19.4B	658.4M	757.1M	719.3M
Property Plant Equipment	27.2B	27.8B	29.2B	42.0B	48.3B	50.7B
Long Term Debt	19.0B	14.8B	21.1B	20.8B	23.9B	12.4B
Net Tangible Assets	19.7B	17.0B	20.1B	31.8B	36.6B	38.4B
Other Stockholder Equity	(468.3M)	(3.6B)	(6.4B)	1.3B	1.2B	1.2B
Deferred Long Term Liab	137.0M	127.5M	178.8M	217.7M	250.3M	157.6M
Short Long Term Debt	20.5B	26.9B	20.1B	29.7B	34.2B	35.9B
Total Current Assets	57.2B	71.0B	85.7B	83.6B	96.2B	56.9B
Non Current Assets Total	65.2B	66.5B	79.3B	89.3B	102.7B	75.9B
Non Currrent Assets Other	36.1B	11.1B	10.7B	7.9B	9.1B	13.4B
Good Will	396.3M	387.2M	423.0M	430.1M	387.1M	491.9M
Non Current Liabilities Total	32.7B	38.5B	52.9B	52.0B	59.8B	44.1B
Non Current Liabilities Other	6.9B	17.0B	25.1B	5.7M	6.6M	6.3M
Net Debt	22.5B	17.4B	8.6B	19.8B	22.7B	15.2B
Net Invested Capital	78.3B	81.5B	92.9B	110.0B	126.5B	90.4B
Net Working Capital	14.9B	20.3B	35.6B	34.7B	39.9B	27.3B
Property Plant And Equipment Net	27.8B	29.2B	42.0B	70.1B	80.6B	43.2B
Capital Lease Obligations	247.8M	233.9M	209.3M	398.4M	458.1M	300.0M
Property Plant And Equipment Gross	40.4B	43.5B	60.0B	97.2B	111.8B	61.5B

Currently Active Assets on Macroaxis

V	Visa Class A
CRM	Salesforce
CRM	Salesforce
MSFT	Microsoft
V	Visa Class A

Other Information on Investing in China Stock

Balance Sheet is a snapshot of the financial position of China Molybdenum at a specified time, usually calculated after every quarter, six months, or one year. China Molybdenum Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of China Molybdenum and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which China currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

China Research Development vs Selling General Administrative Analysis

Research Development vs Selling General Administrative

Research Development vs Selling General Administrative Correlation Analysis

Correlation Coefficient

Research Development

Selling General Administrative

China Molybdenum fundamental ratios Correlations

China Molybdenum Account Relationship Matchups

High Positive Relationship

High Negative Relationship

China Molybdenum fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in China Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Other Assets	+ 0.99	Total Assets
Property Plant Equipment	+ 0.99	Total Assets
Inventory	+ 0.99	Total Current Liabilities
Total Liab	+ 0.99	Other Assets
Property Plant Equipment	+ 0.99	Other Assets

Other Stockholder Equity	- 0.49	Other Current Assets
Non Current Assets Total	- 0.48	Intangible Assets
Non Current Assets Total	- 0.46	Net Receivables
Deferred Long Term Liab	- 0.45	Net Receivables
Short Term Debt	- 0.41	Net Receivables
Short Long Term Debt	- 0.41	Net Receivables